Guggenheim Reiterates Buy on Seagen, Maintains $170 Price Target
Guggenheim analyst Michael Schmidt reiterates Seagen (NASDAQ:SGEN) with a Buy and maintains $170 price target.
US Stocks Recover After Recording Worst Week Of 2023, Market Volatility Declines
US stocks settled slightly higher on Monday, after Wall Street's major benchmarks recorded the biggest percentage declines of the year during the last week.
On the economic data front, durable goods orders in the US dropped 4.5% month-over-month in January, the most since April 2020. Pending home sales in the US jumped 8.1% month-over-month in January.
Why Smith Micro Software Shares Are Trading Lower By Over 46%? Here Are Other Stocks Moving In Monday’s Mid-Day Session
Gainers
Lucira Health, Inc. (NASDAQ: LHDX) jumped 354% to $0.6369 after the company announced FDA authorization for its at-home combination COVID-19 & flu test.
Analyst Cautions Investors On Overreacting To ‘Early-Stage’ Pfizer/Seagen Discussions
In a news article by the Wall Street Journal, Pfizer Inc (NYSE:PFE) is reportedly in early-stage talks to acquire Seagen Inc (NASDAQ:SGEN) for…
Union Pacific, Kosmos Energy, Fisker And Other Big Stocks Moving Higher On Monday
U.S. stocks traded higher, with the Dow Jones gaining more than 300 points on Monday. Here are some big stocks recording gains in today’s session.
Nasdaq, S&P 500 Futures Rebound In New Trading Week But Rising Bond Yields Remain A Risk
US stocks are coming off a lackluster week and early indications suggest a reversal in sentiment in the new trading week. While rising bond yields could be a cause of concern, the recent weakness could trigger bargain-hunting-related buying.
Seagen, Occidental Petroleum And 3 Stocks To Watch Heading Into Monday
With US futures trading higher this morning on Monday, some of the stocks that may grab investor focus today are as follows:
Pfizer In Early Talks To Buy Cancer-Focused Seagen: WSJ
Pfizer Inc (NYSE:PFE) is in early discussions to purchase biotechnology company Seagen Inc (NASDAQ:SGEN), The Wall Street Journal reported late on…
Oppenheimer Maintains Outperform on Seagen, Raises Price Target to $180
Oppenheimer analyst Jay Olson maintains Seagen (NASDAQ:SGEN) with a Outperform and raises the price target from $178 to $180.
JMP Securities Maintains Market Outperform Rating for Seagen: Here’s What You Need To Know
JMP Securities has decided to maintain its Market Outperform rating of Seagen (NASDAQ:SGEN) and raise its price target…